$DY

DYCOM INDUSTRIES INC (DY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

DYCOM INDUSTRIES INC (DY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. dy-20260804 0000067215 false 0000067215 2026-08-04 2026-08-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): A

Original reporting
Published Aug 4, 2026, 8:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$DY
Neutral
medium confidence
Mentioned
$DY
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$DYNeutralLow
01

Why it matters

This is a governance update: two independent directors were appointed effective Aug 4, 2026, with terms expiring at the 2027 annual meeting; the board size increased to eleven.

02

Market read

A routine board appointment disclosure with no stated financial or strategic changes, so it is unlikely to drive a sustained repricing by itself.

03

What to watch

Traders may watch whether the new directors later receive committee roles or are tied to specific expertise areas, which is not disclosed here.

Relevance 6/10Novelty 3/10Timing: filed Aug 4, 2026, after-hours/late session disclosure

Background

The filing is an SEC Form 8-K (Item 5.02) reporting director/officer changes and related compensatory arrangements.

Company-level read

Ticker impact

$DYNeutralMedium confidence
Context

Dycom Industries appointed David J. Fallon and Michael C. Lenz to its board, increasing directors from nine to eleven.

Expected impact

Likely limited, with any move more sentiment-driven than fundamental.

Evidence & confidence

The 8-K discloses director appointments and compensation terms but no operational, financial, or strategic change, and no committee assignments were made.

Market effects

Minimal direct read-through to the construction/engineering services sector without any stated strategy or financial guidance changes.

No specific regional impact indicated beyond US-listed governance news.

No global catalyst described.

Counterpoint

The appointments could be a governance or oversight refresh ahead of a larger strategic shift, but the filing provides no such linkage.

Key entities

  • Dycom Industries, Inc.

    US-listed company filing the 8-K reporting board appointments and director compensation framework.

  • David J. Fallon

    Appointed to Dycom’s board effective Aug 4, 2026; independent; no committee assignments disclosed.

  • Michael C. Lenz

    Appointed to Dycom’s board effective Aug 4, 2026; independent; no committee assignments disclosed.

Related articles

$DYMed

Dycom Industries (DY) – Analysts’ Recent Ratings Updates

Dycom Industries (NYSE: DY) saw multiple analyst rating and target changes in late May and June 2026. KeyCorp raised its target to $610 (overweight). UBS reaffirmed “buy” with a $611 target. JPMorgan, Wells Fargo, Cantor Fitzgerald, and others lifted targets to as high as $654, with several moving to “overweight.”

$DYMedAI 9/10

Dycom Industries Stock Just Skyrocketed. It's the Latest Winner from Data Center Demand.

Dycom Industries said it will acquire National Technology Integrators for $275 million, expanding low-voltage inside-plant structured cabling work for data centers. In its latest quarter, non-GAAP adjusted EPS rose 84.9% to $4.42, beating a $2.73 estimate, with backlog up 46.5% to a record $11.91 billion. Dycom raised fiscal 2027 contract revenue guidance to $7.38–$7.65 billion.

$SNOWMedAI 9/10

Thursday's Stocks to Watch

The article highlights Snowflake (SNOW) after it raised its full-year revenue forecast in its quarterly report, citing stronger demand for AI workloads and cloud migrations. It also notes Dycom (DY) Q1 non-GAAP EPS of $4.42 on $1.96B revenue (+55.6% Y/Y) and a backlog of $11.906B (+46.5%), plus Salesforce (CRM) Q1 non-GAAP EPS $3.88 and revenue $11.13B (+13.2% Y/Y) and a plan to repurchase up to $25B.

$UALMedAI 9/10

Stocks Settle Mixed on Conflicting US-Iran Signals

Stocks ended mixed as markets weighed conflicting US-Iran signals. The IEA said global oil inventories fell about 4 million bpd in March-April and remain “severely undersupplied” until October even if conflict ends next month; Goldman estimates nearly 500 million bbl drawn from crude stocks. S&P 500 Q1 earnings beat rates were 83% (of 475 firms). WTI fell over 5%, lifting airlines while energy stocks declined.

$UALMedAI 8/10

Stocks Mixed Awaiting Fresh Iran News

Markets were mixed as investors awaited fresh Iran-related developments and priced a 2% chance of a -25 bp FOMC cut at the June 16-17 meeting. Earnings were supportive: 83% of 475 S&P 500 Q1 reporters beat estimates; Q1 S&P 500 earnings are projected up 12% y/y (about +3% excluding tech, weakest in two years). WTI fell over 3%, lifting airlines while weighing energy stocks.